Earlybird is a venture capital investor focused on European technology companies. Founded in 1997, Earlybird's pan-European approach backs early-stage, growth, and development phases of portfolio companies – providing financial resources, strategic support, and access to an international network & capital markets.
We operate a family of funds with different focus areas. The Digital West team invests primarily in early-stage digital technology opportunities emerging in Western Europe. The Digital East team targets similar companies in Eastern Europe and the Health team back disruptive startups across Europe. The newer Earlybird-X team invests in pre-seed in Western Europe and university spinoffs; the Growth Opportunities Fund is a pan-Earlybird growth fund.
With EUR 2 billion under management across all fund streams, 8 IPOs, and 30 trade sales, Earlybird is one of Europe’s most established and active venture capital firms.
At Earlybird Health, we especially focus on the potential to improve patient outcomes and overcome inefficiencies in healthcare systems across Europe. Earlybird Health invests from Seed to Series C - deploying up to 15 million per company throughout the holding period. The Health Fund focuses on innovative companies in the areas of medical devices, diagnostics, digital health, R&D tools, platform technologies and biopharma.
The Earlybird Health Fellowship Program allows for highly motivated and talented individuals passionate about working with early-stage companies and in the European startup ecosystem to join the Health Investment team.
Our Fellows get the opportunity to work with a very experienced investment team, gain exposure to some of the brightest healthcare entrepreneurs of our time, access to high-quality deal flow, and be part of the decision-making process.
The fellowship is structured to engage with people located in major healthcare startup hubs across Europe